Waters (NYSE:WAT – Free Report) had its price objective boosted by Deutsche Bank Aktiengesellschaft from $310.00 to $325.00 in a report published on Monday morning, Benzinga reports. The firm currently has a hold rating on the medical instruments supplier’s stock.
WAT has been the subject of a number of other reports. Leerink Partnrs raised shares of Waters from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 1st. Wells Fargo & Company raised their target price on Waters from $380.00 to $415.00 and gave the stock an “overweight” rating in a research report on Monday. TD Cowen lifted their price objective on Waters from $363.00 to $410.00 and gave the company a “hold” rating in a report on Monday. Cfra set a $389.00 target price on Waters in a research note on Thursday, October 17th. Finally, Jefferies Financial Group upgraded Waters from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $355.00 to $415.00 in a research report on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating, three have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $365.85.
Get Our Latest Stock Analysis on Waters
Waters Price Performance
Waters (NYSE:WAT – Get Free Report) last announced its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. The firm had revenue of $740.30 million during the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. Waters’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.84 EPS. As a group, equities research analysts anticipate that Waters will post 11.63 earnings per share for the current year.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in WAT. Itau Unibanco Holding S.A. purchased a new position in shares of Waters in the 2nd quarter worth $33,000. Kennebec Savings Bank bought a new stake in Waters during the third quarter valued at about $33,000. Blue Trust Inc. raised its holdings in Waters by 190.2% during the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier’s stock valued at $35,000 after acquiring an additional 78 shares during the period. Ashton Thomas Securities LLC bought a new stake in Waters during the third quarter valued at about $35,000. Finally, TFC Financial Management Inc. increased its holdings in shares of Waters by 19,900.0% in the second quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier’s stock worth $58,000 after purchasing an additional 199 shares during the last quarter. Institutional investors own 94.01% of the company’s stock.
About Waters
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
Featured Stories
- Five stocks we like better than Waters
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- NXP Semiconductors Nears Rock Bottom: A Buy Signal Is Expected
- EV Stocks and How to Profit from Them
- NVIDIA, Sherwin-Williams Join the Dow: What Investors Should Know
- 3 Monster Growth Stocks to Buy Now
- 2 Stocks Spinning Off Divisions to Boost Shareholder Value
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.